Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
KEGG_2021_Human,Vascular smooth muscle contraction,5/133,0.0002728334873384258,0.0351955198666569,0,0,9.541859567901234,78.30669118713566,PPP1CB;ACTA2;ADCY9;MYH11;PRKG1
KEGG_2021_Human,cGMP-PKG signaling pathway,5/167,0.0007718162765208855,0.0497821498355971,0,0,7.526291723822588,53.9391567306419,PPP1CB;ADCY9;ATP2B4;MEF2D;PRKG1
KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,4/150,0.0040095954520207,0.1724126044368922,0,0,6.60474440360842,36.4520131932931,PPP1CB;ADCY9;CACNA2D3;ATP2B4
KEGG_2021_Human,Salivary secretion,3/93,0.007540586362197,0.2431839101808555,0,0,7.96144578313253,38.911210652087526,ADCY9;ATP2B4;PRKG1
KEGG_2021_Human,Glycosphingolipid biosynthesis,2/45,0.0160506176078205,0.3356891796271995,0,0,11.002768549280177,45.46352711662799,GLB1;ST3GAL2
KEGG_2021_Human,Platelet activation,3/124,0.0163904365197682,0.3356891796271995,0,0,5.912476351687743,24.306528790465403,PPP1CB;ADCY9;PRKG1
KEGG_2021_Human,Apelin signaling pathway,3/137,0.0212959777674159,0.3356891796271995,0,0,5.335371336090631,20.53710908272721,ACTA2;ADCY9;MEF2D
KEGG_2021_Human,Endocrine and other factor-regulated calcium reabsorption,2/53,0.0218528616042719,0.3356891796271995,0,0,9.27310924369748,35.45502287445614,ADCY9;ATP2B4
KEGG_2021_Human,Regulation of lipolysis in adipocytes,2/55,0.0234201753228278,0.3356891796271995,0,0,8.922282120395328,33.49565175775767,ADCY9;PRKG1
KEGG_2021_Human,Oxytocin signaling pathway,3/154,0.0287961924827407,0.3714708830273556,0,0,4.73063113380675,16.78197121639173,PPP1CB;ADCY9;CACNA2D3
KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,2/77,0.0434404098426665,0.3902135619232808,0,0,6.298095238095238,19.753126534025004,CACNA2D3;CTNNA3
KEGG_2021_Human,Bacterial invasion of epithelial cells,2/77,0.0434404098426665,0.3902135619232808,0,0,6.298095238095238,19.753126534025004,CAV2;CTNNA3
KEGG_2021_Human,Gap junction,2/88,0.0551496350594298,0.3902135619232808,0,0,5.489479512735326,15.906893057840293,ADCY9;PRKG1
KEGG_2021_Human,Focal adhesion,3/201,0.0558166047494675,0.3902135619232808,0,0,3.5991237677984667,10.38593343060646,PPP1CB;CAV2;PGF
KEGG_2021_Human,Proteoglycans in cancer,3/205,0.0585261810882877,0.3902135619232808,0,0,3.527138255994274,10.01100979577953,PPP1CB;CAV2;TWIST2
KEGG_2021_Human,Dilated cardiomyopathy,2/96,0.0642800829883674,0.3902135619232808,0,0,5.020263424518744,13.77814031431165,ADCY9;CACNA2D3
KEGG_2021_Human,Circadian entrainment,2/97,0.065455178175553,0.3902135619232808,0,0,4.967167919799499,13.542435321821053,ADCY9;PRKG1
KEGG_2021_Human,Phosphatidylinositol signaling system,2/97,0.065455178175553,0.3902135619232808,0,0,4.967167919799499,13.542435321821053,INPP4B;PPIP5K2
KEGG_2021_Human,cAMP signaling pathway,3/216,0.0662918606479058,0.3902135619232808,0,0,3.3431189546920077,9.072182307496025,PPP1CB;ADCY9;ATP2B4
KEGG_2021_Human,Aldosterone synthesis and secretion,2/98,0.0666375028628048,0.3902135619232808,0,0,4.915178571428571,13.312700968810276,ADCY9;ATP2B4
KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,2/98,0.0666375028628048,0.3902135619232808,0,0,4.915178571428571,13.312700968810276,PPP1CB;ADCY9
KEGG_2021_Human,Longevity regulating pathway,2/102,0.0714374607347741,0.3902135619232808,0,0,4.717619047619047,12.44948005343785,ADCY9;HSPA1A
KEGG_2021_Human,Pancreatic secretion,2/102,0.0714374607347741,0.3902135619232808,0,0,4.717619047619047,12.44948005343785,ADCY9;ATP2B4
KEGG_2021_Human,Other glycan degradation,1/18,0.0746651782709374,0.3902135619232808,0,0,13.76955017301038,35.728422579909434,GLB1
KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",2/106,0.0763466136014558,0.3902135619232808,0,0,4.535256410256411,11.666818322795091,ADCY9;MEF2D
KEGG_2021_Human,Glycosaminoglycan degradation,1/19,0.0786476946512038,0.3902135619232808,0,0,13.003921568627453,33.06607217254294,GLB1
KEGG_2021_Human,Lysosome,2/128,0.105080659667604,0.4429651181856551,0,0,3.7392290249433104,8.424584088559756,AP3M1;GLB1
KEGG_2021_Human,Folate biosynthesis,1/26,0.1060549125253618,0.4429651181856551,0,0,9.359529411764706,21.000895961244385,MOCS1
KEGG_2021_Human,Oocyte meiosis,2/129,0.106448981889576,0.4429651181856551,0,0,3.709598800149981,8.309833143000272,PPP1CB;ADCY9
KEGG_2021_Human,Purine metabolism,2/129,0.106448981889576,0.4429651181856551,0,0,3.709598800149981,8.309833143000272,NT5C3A;ADCY9
KEGG_2021_Human,Relaxin signaling pathway,2/129,0.106448981889576,0.4429651181856551,0,0,3.709598800149981,8.309833143000272,ACTA2;ADCY9
KEGG_2021_Human,Prion disease,3/273,0.1132990642676859,0.456736852829109,0,0,2.629718875502008,5.726802881095643,SEM1;CAV2;HSPA1A
KEGG_2021_Human,Estrogen signaling pathway,2/137,0.1175650683947083,0.4595725400884053,0,0,3.4883597883597885,7.467752699680994,ADCY9;HSPA1A
KEGG_2021_Human,Galactose metabolism,1/31,0.125136605265329,0.4747830023302191,0,0,7.79764705882353,16.206234277302418,GLB1
KEGG_2021_Human,SNARE interactions in vesicular transport,1/33,0.1326560603433392,0.4770064885079039,0,0,7.309558823529412,14.765276023510664,SNAP29
KEGG_2021_Human,MAPK signaling pathway,3/294,0.1331180898161592,0.4770064885079039,0,0,2.4373369767730715,4.914935473287768,CACNA2D3;PGF;HSPA1A
KEGG_2021_Human,Mucin type O-glycan biosynthesis,1/36,0.1438156274160286,0.5014112415315592,0,0,6.6820168067226895,12.957921780117758,ST3GAL2
KEGG_2021_Human,Hippo signaling pathway,2/163,0.1554565178753723,0.5277339685769218,0,0,2.9211771665187816,5.437447670750615,PPP1CB;CTNNA3
KEGG_2021_Human,Homologous recombination,1/41,0.1621003778502616,0.535554994082485,0,0,5.845294117647059,10.635743648833245,SEM1
KEGG_2021_Human,Vasopressin-regulated water reabsorption,1/44,0.1728854067820549,0.535554994082485,0,0,5.436662106703146,9.54202860693275,ADCY9
KEGG_2021_Human,Proteasome,1/46,0.1799990825290058,0.535554994082485,0,0,5.1945098039215685,8.907563723274029,SEM1
KEGG_2021_Human,Sphingolipid metabolism,1/49,0.190556361783656,0.535554994082485,0,0,4.869117647058824,8.072058613293224,GLB1
KEGG_2021_Human,Alcoholism,2/186,0.1906314958603786,0.535554994082485,0,0,2.5530538302277432,4.231464749757856,PPP1CB;HDAC9
KEGG_2021_Human,Vibrio cholerae infection,1/50,0.1940455128548384,0.535554994082485,0,0,4.769507803121249,7.820383303288144,ADCY9
KEGG_2021_Human,Pathways in cancer,4/531,0.1949611096319657,0.535554994082485,0,0,1.794511038089508,2.9339451138704566,ADCY9;HEY2;CTNNA3;PGF
KEGG_2021_Human,Ovarian steroidogenesis,1/51,0.1975197978687494,0.535554994082485,0,0,4.673882352941177,7.580646707679503,ADCY9
KEGG_2021_Human,Glycosaminoglycan biosynthesis,1/53,0.2044240199319846,0.535554994082485,0,0,4.493665158371041,7.133958175164451,ST3GAL2
KEGG_2021_Human,Pyrimidine metabolism,1/56,0.2146704142378106,0.535554994082485,0,0,4.247914438502674,6.536059430207652,NT5C3A
KEGG_2021_Human,Epstein-Barr virus infection,2/202,0.2156901596901284,0.535554994082485,0,0,2.346904761904762,3.599946191470492,SEM1;CD58
KEGG_2021_Human,Legionellosis,1/57,0.2180568084643899,0.535554994082485,0,0,4.171848739495799,6.353724215387732,HSPA1A
KEGG_2021_Human,Endometrial cancer,1/58,0.2214287694166872,0.535554994082485,0,0,4.098452012383901,6.179048898114302,CTNNA3
KEGG_2021_Human,Notch signaling pathway,1/59,0.2247863578796311,0.535554994082485,0,0,4.027586206896552,6.011594699734063,HEY2
KEGG_2021_Human,Long-term depression,1/60,0.228129634375795,0.535554994082485,0,0,3.9591226321036888,5.850954699068187,PRKG1
KEGG_2021_Human,Mineral absorption,1/60,0.228129634375795,0.535554994082485,0,0,3.9591226321036888,5.850954699068187,ATP2B4
KEGG_2021_Human,Rap1 signaling pathway,2/210,0.2283374005778037,0.535554994082485,0,0,2.2557234432234434,3.33154769304085,ADCY9;PGF
KEGG_2021_Human,Regulation of actin cytoskeleton,2/218,0.24103744076931,0.5536440984159708,0,0,2.1712962962962963,3.0893268878825126,PPP1CB;MYH11
KEGG_2021_Human,Cortisol synthesis and secretion,1/65,0.2446334388349638,0.5536440984159708,0,0,3.6488970588235294,5.137626467495332,ADCY9
KEGG_2021_Human,Long-term potentiation,1/67,0.2511368678628957,0.5551446919746692,0,0,3.537967914438503,4.888612632693461,PPP1CB
KEGG_2021_Human,Amphetamine addiction,1/69,0.2575849502210434,0.5551446919746692,0,0,3.4335640138408303,4.657305832354093,PPP1CB
KEGG_2021_Human,Thermogenesis,2/232,0.2633364603371012,0.5551446919746692,0,0,2.03768115942029,2.718924323292658,ADCY9;PRKG1
KEGG_2021_Human,Adherens junction,1/71,0.2639781514229198,0.5551446919746692,0,0,3.335126050420168,4.442017496799639,CTNNA3
KEGG_2021_Human,Inositol phosphate metabolism,1/73,0.270316933121591,0.5551446919746692,0,0,3.242156862745098,4.241260511650994,INPP4B
KEGG_2021_Human,Calcium signaling pathway,2/240,0.2760929316605703,0.5551446919746692,0,0,1.9683873549419768,2.5333494863845942,ADCY9;ATP2B4
KEGG_2021_Human,Thyroid hormone synthesis,1/75,0.2766017531435907,0.5551446919746692,0,0,3.1542130365659777,4.053720538658391,ADCY9
KEGG_2021_Human,Gastric acid secretion,1/76,0.2797240695996395,0.5551446919746692,0,0,3.112,3.964537464528065,ADCY9
KEGG_2021_Human,Antigen processing and presentation,1/78,0.285928797233274,0.5588608309559447,0,0,3.030863254392666,3.7946785586949976,HSPA1A
KEGG_2021_Human,Endocytosis,2/252,0.2952071965614739,0.5589851903189206,0,0,1.8727619047619048,2.284915239587644,CAV2;HSPA1A
KEGG_2021_Human,Complement and coagulation cascades,1/85,0.3072321872240103,0.5589851903189206,0,0,2.777310924369748,3.2776476730175657,A2M
KEGG_2021_Human,ErbB signaling pathway,1/85,0.3072321872240103,0.5589851903189206,0,0,2.777310924369748,3.2776476730175657,NRG2
KEGG_2021_Human,Insulin secretion,1/86,0.3102237984570717,0.5589851903189206,0,0,2.744498269896194,3.212329044289917,ADCY9
KEGG_2021_Human,Cardiac muscle contraction,1/87,0.3132026404530267,0.5589851903189206,0,0,2.7124487004103965,3.1488949448167403,CACNA2D3
KEGG_2021_Human,GABAergic synapse,1/89,0.3191222318731329,0.5589851903189206,0,0,2.6505347593582886,3.02739064758815,ADCY9
KEGG_2021_Human,Bile secretion,1/90,0.3220630883751708,0.5589851903189206,0,0,2.6206212822207533,2.969184421732711,ADCY9
KEGG_2021_Human,Hypertrophic cardiomyopathy,1/90,0.3220630883751708,0.5589851903189206,0,0,2.6206212822207533,2.969184421732711,CACNA2D3
KEGG_2021_Human,Morphine addiction,1/91,0.3249913897203026,0.5589851903189206,0,0,2.591372549019608,2.9125902540604933,ADCY9
KEGG_2021_Human,GnRH signaling pathway,1/93,0.3308105386720461,0.5615073616933415,0,0,2.534782608695652,2.8040004962252554,ADCY9
KEGG_2021_Human,mRNA surveillance pathway,1/98,0.3451423773061049,0.5701726082583414,0,0,2.4035172832019405,2.55685750192156,PPP1CB
KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,1/100,0.3507897886854045,0.5701726082583414,0,0,2.354723707664884,2.46673350535558,NOX4
KEGG_2021_Human,Progesterone-mediated oocyte maturation,1/100,0.3507897886854045,0.5701726082583414,0,0,2.354723707664884,2.46673350535558,ADCY9
KEGG_2021_Human,Melanogenesis,1/101,0.3535954159741651,0.5701726082583414,0,0,2.331058823529412,2.423373210337424,ADCY9
KEGG_2021_Human,Insulin resistance,1/108,0.3729020612665014,0.5903589283163554,0,0,2.177789994502474,2.148257995201809,PPP1CB
KEGG_2021_Human,Toxoplasmosis,1/112,0.3836773699000366,0.5903589283163554,0,0,2.098887122416534,2.0106357656935216,HSPA1A
KEGG_2021_Human,Cholinergic synapse,1/113,0.3863424770334258,0.5903589283163554,0,0,2.080042016806723,1.9781845571969965,ADCY9
KEGG_2021_Human,Glutamatergic synapse,1/114,0.3889961930766683,0.5903589283163554,0,0,2.0615304528891203,1.9464676187704355,ADCY9
KEGG_2021_Human,Leukocyte transendothelial migration,1/114,0.3889961930766683,0.5903589283163554,0,0,2.0615304528891203,1.9464676187704355,CTNNA3
KEGG_2021_Human,"Growth hormone synthesis, secretion and action",1/119,0.4020955844211759,0.5920790067013963,0,0,1.973678963110668,1.79815070564473,ADCY9
KEGG_2021_Human,Thyroid hormone signaling pathway,1/121,0.4072572721420906,0.5920790067013963,0,0,1.9405882352941175,1.743250157166395,RCAN2
KEGG_2021_Human,Dopaminergic synapse,1/132,0.4348691019791356,0.5920790067013963,0,0,1.776650202065559,1.4794347596036352,PPP1CB
KEGG_2021_Human,Autophagy,1/137,0.4469958985068555,0.5920790067013963,0,0,1.7108996539792387,1.377626427274088,SNAP29
KEGG_2021_Human,Yersinia infection,1/137,0.4469958985068555,0.5920790067013963,0,0,1.7108996539792387,1.377626427274088,PKN1
KEGG_2021_Human,Insulin signaling pathway,1/137,0.4469958985068555,0.5920790067013963,0,0,1.7108996539792387,1.377626427274088,PPP1CB
KEGG_2021_Human,PI3K-Akt signaling pathway,2/354,0.4514891362233024,0.5920790067013963,0,0,1.323187229437229,1.052203735170072,PKN1;PGF
KEGG_2021_Human,Fluid shear stress and atherosclerosis,1/139,0.4517742795162752,0.5920790067013963,0,0,1.6859335038363172,1.3395965768152946,CAV2
KEGG_2021_Human,Measles,1/139,0.4517742795162752,0.5920790067013963,0,0,1.6859335038363172,1.3395965768152946,HSPA1A
KEGG_2021_Human,Signaling pathways regulating pluripotency of stem cells,1/143,0.4612089470988867,0.5920790067013963,0,0,1.6381110190555097,1.2677408194346094,ZFHX3
KEGG_2021_Human,Spinocerebellar ataxia,1/143,0.4612089470988867,0.5920790067013963,0,0,1.6381110190555097,1.2677408194346094,SEM1
KEGG_2021_Human,Amyotrophic lateral sclerosis,2/364,0.4658413032001134,0.5920790067013963,0,0,1.2859773743751644,0.9823713026070304,SEM1;NRG2
KEGG_2021_Human,Breast cancer,1/147,0.4704831044733509,0.5920790067013963,0,0,1.5929089443996778,1.2010457464252422,HEY2
KEGG_2021_Human,Cell adhesion molecules,1/148,0.4727768813863378,0.5920790067013963,0,0,1.5819927971188474,1.1851209714059467,CD58
KEGG_2021_Human,Phospholipase D signaling pathway,1/148,0.4727768813863378,0.5920790067013963,0,0,1.5819927971188474,1.1851209714059467,ADCY9
KEGG_2021_Human,Retrograde endocannabinoid signaling,1/148,0.4727768813863378,0.5920790067013963,0,0,1.5819927971188474,1.1851209714059467,ADCY9
KEGG_2021_Human,Alzheimer disease,2/369,0.4729358484372303,0.5920790067013963,0,0,1.2681328662255094,0.9495722174541033,SEM1;NOX4
KEGG_2021_Human,Gastric cancer,1/149,0.4750608370792901,0.5920790067013963,0,0,1.5712241653418124,1.1694816374365784,CTNNA3
KEGG_2021_Human,Spliceosome,1/150,0.4773350131546141,0.5920790067013963,0,0,1.5606000789577577,1.154121033905946,HSPA1A
KEGG_2021_Human,Cushing syndrome,1/155,0.4885606405437286,0.597266350948919,0,0,1.5095492742551566,1.0812775841638456,ADCY9
KEGG_2021_Human,Cellular senescence,1/156,0.4907770015549256,0.597266350948919,0,0,1.4997343453510437,1.0674590557167951,PPP1CB
KEGG_2021_Human,Tight junction,1/169,0.5187402396645594,0.624581436198589,0,0,1.3827731092436977,0.9075859272131256,MYH11
KEGG_2021_Human,Protein processing in endoplasmic reticulum,1/171,0.5229053884453303,0.624581436198589,0,0,1.3663667820069203,0.8858903700134679,HSPA1A
KEGG_2021_Human,NOD-like receptor signaling pathway,1/181,0.5432026318076294,0.6393530763843753,0,0,1.2898039215686274,0.7871323251434355,PKN1
KEGG_2021_Human,Axon guidance,1/182,0.545184793816134,0.6393530763843753,0,0,1.282612934676633,0.7780720881198544,SLIT3
KEGG_2021_Human,Neutrophil extracellular trap formation,1/189,0.5588238918519959,0.6494439824225897,0,0,1.2344180225281602,0.7183336427853815,HDAC9
KEGG_2021_Human,Chemokine signaling pathway,1/192,0.5645447248064708,0.6502345491074529,0,0,1.2148444718201417,0.6945699173945614,ADCY9
KEGG_2021_Human,Pathogenic Escherichia coli infection,1/197,0.5739169454100319,0.6551795217512754,0,0,1.1835534213685477,0.6571924036676114,MYH11
KEGG_2021_Human,Viral carcinogenesis,1/203,0.5849007441298377,0.6561060521108614,0,0,1.148048922539313,0.6157136930154435,HDAC9
KEGG_2021_Human,Diabetic cardiomyopathy,1/203,0.5849007441298377,0.6561060521108614,0,0,1.148048922539313,0.6157136930154435,PPP1CB
KEGG_2021_Human,Lipid and atherosclerosis,1/215,0.6060355771307744,0.6699706384613964,0,0,1.0830126443100605,0.542390695659147,HSPA1A
KEGG_2021_Human,Pathways of neurodegeneration,2/475,0.6092815989797539,0.6699706384613964,0,0,0.9786066646531764,0.4848748655535486,SEM1;NOX4
KEGG_2021_Human,Human T-cell leukemia virus 1 infection,1/219,0.6128413592127502,0.6699706384613964,0,0,1.0629249865083648,0.5204603381020326,ADCY9
KEGG_2021_Human,Human cytomegalovirus infection,1/225,0.6228327200784859,0.6751716041186947,0,0,1.034138655462185,0.4896411818744058,ADCY9
KEGG_2021_Human,Ras signaling pathway,1/232,0.6341675641682093,0.681730131480825,0,0,1.0024446142093202,0.4565554428077985,PGF
KEGG_2021_Human,Chemical carcinogenesis,1/239,0.6451656084856591,0.6869379085362354,0,0,0.9726149283242708,0.4262467783968463,ADCY9
KEGG_2021_Human,Shigellosis,1/246,0.6558367463353773,0.6869379085362354,0,0,0.9444897959183672,0.3984267710054012,TNIP1
KEGG_2021_Human,Salmonella infection,1/249,0.6603124082053735,0.6869379085362354,0,0,0.93292220113852,0.387202092294653,PKN1
KEGG_2021_Human,Parkinson disease,1/249,0.6603124082053735,0.6869379085362354,0,0,0.93292220113852,0.387202092294653,SEM1
KEGG_2021_Human,Huntington disease,1/306,0.7352088044460812,0.7587354861883557,0,0,0.756374156219865,0.2326612444464881,SEM1
KEGG_2021_Human,Human papillomavirus infection,1/331,0.7626665802979676,0.7808253084003002,0,0,0.6981818181818182,0.1891614220075541,HEY2
KEGG_2021_Human,Neuroactive ligand-receptor interaction,1/341,0.7728440632013469,0.7850148358501869,0,0,0.6773010380622837,0.1745255634137426,GRID1
KEGG_2021_Human,Olfactory transduction,1/440,0.8529873494645431,0.8596513131322349,0,0,0.5219080798606458,0.0829888972161827,PRKG1
KEGG_2021_Human,Herpes simplex virus 1 infection,1/498,0.88618483939829,0.88618483939829,0,0,0.4596283583856078,0.0555367694282845,PPP1CB
